Karachi: Ghani Global Holdings has reported a profit of Rs. 145 million for the year 2024, according to its latest performance review. The company, a leader in specialized pharmaceutical glass manufacturing, attributes this success to optimal plant capacity utilization and significant market penetration in both Chinese and European markets.

According to information available from the Pakistan Stock Exchange (PSX), Ghani Global Holdings, a subsidiary of Ghani Global Group, operates a high-tech glass tubing manufacturing facility in Pakistan, recognized for its premium quality comparable to European standards. The plant, which serves as an “Import Substitute,” has been crucial in saving foreign exchange for the country with a furnace capacity of 22 tons per day and a glass tube production capacity of 18 tons per day.

The company’s financial health has shown robust growth with a profit of Rs. 145 million in June 2024, up from a loss in previous years. The shift to profitability is largely due to the company’s strategic focus on capturing a 70% share of the Chinese glass tube market and increasing its footprint in the European market in Pakistan from 15-20% to a targeted 50% in the next 1-2 years.

In addition to tube production, Ghani Global Holdings has been expanding its value addition business through the manufacturing of ampoules and vials from in-house produced glass tubes. The company currently operates 16 ampoule machines and 5 vial machines, with plans to increase its ampoule production capacity from 40 million to over 55 million per month, following the acquisition of six high-tech ampoule machines from Europe.

This expansion not only enhances Ghani Global Holdings’ production capabilities but also contributes to increased profit margins, positioning the company for continued growth and success in the pharmaceutical and glass manufacturing industries.

The post Ghani Global Holdings Reports Strong Performance and Expansion in Glass Manufacturing appeared first on AsiaNet-Pakistan.